Safety and Efficacy Evaluation of Next-generation CD19-UCART

NCT05381181 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD19-UCART

Sponsor

Bioray Laboratories

Collaborators

[object Object]